Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2001
08/02/2001WO2001055314A2 Digestive system related nucleic acids, proteins and antibodies
08/02/2001WO2001055313A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055312A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055311A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055310A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055309A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055308A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055307A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055304A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055303A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055302A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055301A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055294A1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
08/02/2001WO2001055215A1 Therapeutic peptides
08/02/2001WO2001055212A2 Delivery of therapeutic biological from implantable tissue matrices
08/02/2001WO2001055211A2 Fil-1 theta dnas and polypeptides
08/02/2001WO2001055210A2 Human cyr61
08/02/2001WO2001055208A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055206A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055205A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055204A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055203A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055202A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055201A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055200A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
08/02/2001WO2001055173A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001055166A1 Cloned human lysophospholipase
08/02/2001WO2001055163A1 Nucleic acids, proteins, and antibodies
08/02/2001WO2001054733A1 Nucleic acids, proteins and antibodies
08/02/2001WO2001054719A2 Vaccine for the prophylactic or therapeutic immunization against hiv
08/02/2001WO2001054716A2 Genetically engineered tumor cell vaccines
08/02/2001WO2001054712A1 Compositions and methods for the early diagnosis of ovarian cancer
08/02/2001WO2001054709A1 Vzv orf29p protein-related compositions and methods
08/02/2001WO2001054708A1 22 human secreted proteins
08/02/2001WO2001054706A2 Method for treating kidney disorders
08/02/2001WO2001054672A2 Closure of bacterial ghosts
08/02/2001WO2001054474A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001054473A2 Nucleic acids, proteins, and antibodies
08/02/2001WO2001018048A3 Smooth muscle cell promoter and uses thereof
08/02/2001WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES
08/02/2001WO2001005826A3 Chimeric polypeptides of serum albumin and uses related thereto
08/02/2001WO2001004305A3 Human proteins involved in detoxification
08/02/2001WO2001004155A3 Feline interleukin-12 as an immune stimulant
08/02/2001WO2000070036A3 Genes expressed in hippocampus
08/02/2001WO2000069898A3 Molecular interactions in allergy cells
08/02/2001WO2000065067A3 Prostate-specific polynucleotides, polypeptides and their methods of use
08/02/2001WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/02/2001WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/02/2001WO2000043514A9 Human acid sensing ion channel and uses thereof
08/02/2001WO1999049025A3 Human vault rna
08/02/2001US20010011127 Modulating activity of endogenous protein
08/02/2001US20010011126 Isolated protein; genetic engineering
08/02/2001US20010011124 Genetic engineering
08/02/2001US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides
08/02/2001US20010011073 Uses of transgenic animals containing a type X collagen mutant
08/02/2001US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis
08/02/2001US20010010933 Configuration; vectors; recombinants
08/02/2001US20010010931 Allosteric regulation; gene expression; nucleic acid sequence; chimera
08/02/2001US20010010926 New immunoregulatory protein lst-1
08/02/2001US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's
08/02/2001US20010010815 Adeno-associated vector compositions for expression of factor VIII
08/02/2001US20010010814 Adenoviral vector encoding pro-apoptotic bax gene and uses thereof
08/02/2001DE19955349A1 Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankungen sowie ihre Verwendung zur Identifizierung von pharmakologisch aktiven Substanzen Use of polypeptides or nucleic acids encoding them for the diagnosis or treatment of skin disorders and their use for the identification of pharmacologically active substances
08/02/2001DE10011926A1 Genetisch veränderte Fibroblastenzellen Genetically modified fibroblast cells
08/02/2001DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts
08/02/2001CA2423122A1 Closure of bacterial ghosts
08/02/2001CA2398786A1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
08/02/2001CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
08/02/2001CA2398660A1 Human cyr61
08/02/2001CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
08/02/2001CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides
08/02/2001CA2398411A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2398310A1 Methods for treating kidney disorders with pax2
08/02/2001CA2398242A1 Fil-1 theta dnas and polypeptides
08/02/2001CA2398227A1 17 human secreted proteins
08/02/2001CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha
08/02/2001CA2398003A1 Phosphodiesterases
08/02/2001CA2397839A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
08/02/2001CA2397407A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2397267A1 Peptide fragments and uses thereof as type-1 interferon antagonist
08/02/2001CA2396719A1 22 human secreted proteins
08/02/2001CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
08/02/2001CA2395885A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395872A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395858A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395827A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395816A1 Nucleic acids, proteins and antibodies
08/02/2001CA2395787A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395734A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395693A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395671A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395666A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395654A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395403A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395398A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2395295A1 Nucleic acids, proteins and antibodies
08/02/2001CA2395178A1 Nucleic acids, proteins, and antibodies
08/02/2001CA2394841A1 Nucleic acids, proteins, and antibodies